BPS Biosciences have launched 4 ebooks on generating CAR T-cells

We Biotechno Labs, are glad to announce that our Principal BPS Biosciences have launched 4 ebooks on generating CAR T-cells for helping the scientific community to take their research to next level. Chimeric Antigen Receptor (CAR) T-cell therapy involves genetic modification of patient's T-cells for expressing a CAR specific to tumor antigen.. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer.

CAR-T workflow: custom solutions: https://lnkd.in/gn5z93sD

Functional validation of CAR-T cells: https://lnkd.in/gq8HewsU

Evaluation of CAR expression and antigen binding: https://lnkd.in/gCVD5p75

Tools for research on anti-CD19 CAR T cells: https://lnkd.in/gq8HewsU